Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

Biotechnology

Kymera Therapeutics

Kymera Therapeutics' headquarters in Watertown, MA, United States

Nello Mainolfi

Aimee Mishkin

Jared Gollob

Bruce Jacobs

Brian Adams

Lea Florentino

Noah Goodman

Associate Director, Clinical Pharmacology

Jeremy Chadwick

Karen Weisbach

John Maraganore

Gorjan Hrustanovic

Jeff Albers

Joanna Horobin

David Frank

Jean-Laurent Casanova

David Spiegel

Robert Terkeltaub

Steven A. Carr

Nick Keen

Antonio Sica

Pamela L. Esposito

Bruce Booth

Elena Ridloff

Leigh Morgan

The Research and Development team at Kymera Therapeutics is dedicated to pioneering the discovery and development of innovative small molecule therapeutics that target and degrade disease-causing proteins. Comprising experts in proteomics, medicinal chemistry, biochemical analysis, and translational medicine, the team collaborates to advance drug candidates through rigorous preclinical evaluation, ensuring their efficacy and safety for future clinical trials. Their interdisciplinary approach integrates cutting-edge technologies and scientific expertise to accelerate the path from discovery to impactful therapeutic solutions.

Research and Development

The Leadership Team at Kymera Therapeutics is responsible for setting the strategic direction and overall vision of the company, guiding the development of innovative biopharmaceuticals. This team oversees regulatory compliance, corporate strategy, and operational excellence, while fostering a culture of collaboration and innovation. Together, they navigate the complexities of clinical development and ensure alignment across departments to advance the company’s mission of harnessing protein degradation for transformative therapies.

Leadership Team

The Corporate Functions team at Kymera Therapeutics plays a crucial role in supporting the company’s strategic objectives and operational efficiency. This team encompasses key leadership and specialized roles that oversee corporate strategy, regulatory compliance, financial management, legal affairs, and business development, ensuring that the organization advances its mission of developing innovative therapeutics effectively and in alignment with industry standards.

Corporate Functions

The Quality Assurance and Compliance team at Kymera Therapeutics is responsible for ensuring that all clinical and operational processes adhere to regulatory standards and internal policies. This team works collaboratively to establish and maintain quality systems, manage compliance audits, and oversee contract management, all while supporting the company's mission to develop innovative therapeutics. Their efforts help guarantee the integrity and safety of Kymera's drug development processes.

Quality Assurance and Compliance

The Clinical Operations team at Kymera Therapeutics is responsible for overseeing the planning, execution, and monitoring of clinical trials to evaluate the safety and efficacy of novel therapeutics. This team collaborates closely with regulatory affairs and data management to ensure compliance, streamline operations, and maintain high-quality data integrity throughout the clinical development process. Their ultimate goal is to facilitate timely deliveries of research findings to support the advancement of innovative treatments.

Clinical Operations

Kymera Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Corporate Functions

Quality Assurance and Compliance

Clinical Operations

Offices

Kymera Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Corporate Functions

Quality Assurance and Compliance

Clinical Operations

Offices

Related companies